



Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis





Cardiol Therapeutics Announces FDA Investigational New Drug Application…





Kiniksa Announces FDA Approval of Arcalyst


THE AUTOINFLAMMATORY SIDE OF RECURRENT PERICARDITIS: ENLIGHTENING THE PATHOGENESIS FOR A MORE RATIONAL TREATMENT




